MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, United Kingdom.
Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
JAMA Psychiatry. 2020 Aug 1;77(8):806-813. doi: 10.1001/jamapsychiatry.2020.0316.
Associations between affective symptoms and mortality have been evaluated, but studies have not examined timing or cumulative exposure to affective symptoms over the life course.
To examine how lifetime accumulation and timing of affective symptoms are associated with mortality and identify potential explanatory factors.
DESIGN, SETTING, AND PARTICIPANTS: Data were obtained from the MRC National Survey of Health and Development (1946 British birth cohort), a socially stratified, population-based sample originally consisting of 5362 singleton births in England, Wales, and Scotland during March 1946. The cohort has been followed up 24 times, most recently in 2014-2015. Eligible participants included those flagged for mortality with affective symptom data available at a minimum of 3 time points (n = 3001). Data analysis was conducted from July 2016 to January 2019.
Affective symptoms were assessed at ages 13 to 15 years (teacher-rated questionnaire), 36 years (Present State Examination clinical semistructured interview), 43 years (Psychiatric Symptom Frequency questionnaire), and 53 years (General Health Questionnaire-28). Case-level affective symptoms were determined by those scoring in the top 16th percentile (ie, suggestive of a clinical diagnosis).
Mortality data were obtained from the UK National Health Service Central Register from age 53 to 68 years.
Of 3001 study members (1509 [50.3%] female, 1492 [49.7%] male), 235 individuals (7.8%) died over a 15-year follow-up. After adjustment for sex, those who experienced case-level affective symptoms 1, 2, and 3 to 4 times had 76%, 87%, and 134% higher rates of premature mortality, respectively, compared with those who never experienced case-level symptoms. Case-level symptoms in adolescence only (ages 13-15 years) were associated with a 94% increased rate of mortality, which was unexplained after full adjustment for covariates (hazard ratio, 1.73; 95% CI, 1.10-2.72). Associations between participants with case-level symptoms multiple (2-4) times and mortality were predominately explained by adult health indicators and behaviors. For example, associations for those with case-level symptoms 3 to 4 times were most strongly attenuated by number of health conditions (32.1%), anxiolytic use (28.4%), lung function (24.6%), physical activity (23.9%), smoking (24.6%), antidepressant use (20.1%), diet (16.4%), pulse rate (12.7%), and adult social class (11.2%).
Lifetime accumulation of affective symptoms may be associated with an increased rate of mortality, with explanatory pathways dependent on the duration and timing of symptoms. Future research into causal pathways and potential points of intervention should consider affective symptom history.
已经评估了情感症状与死亡率之间的关系,但研究尚未检查一生中情感症状的累积和出现时间与死亡率之间的关系。
研究终生累积和出现时间的情感症状与死亡率之间的关系,并确定潜在的解释因素。
设计、地点和参与者:数据来自 MRC 国家健康与发展调查(1946 年英国出生队列),这是一个社会分层的基于人群的样本,最初由 1946 年 3 月在英格兰、威尔士和苏格兰出生的 5362 名单胎出生组成。该队列已经进行了 24 次随访,最近一次是在 2014-2015 年。符合条件的参与者包括那些在至少 3 个时间点有情感症状数据且可进行死亡标记的人(n=3001)。数据分析于 2016 年 7 月至 2019 年 1 月进行。
在 13 至 15 岁(教师评定问卷)、36 岁(现在状态检查临床半结构化访谈)、43 岁(精神症状频率问卷)和 53 岁(一般健康问卷-28)时评估情感症状。通过得分在前 16%(即提示临床诊断)的患者来确定病例级别的情感症状。
从英国国家卫生服务中心登记处获得参与者从 53 岁到 68 岁的死亡率数据。
在 3001 名研究对象(1509 名[50.3%]女性,1492 名[49.7%]男性)中,有 235 人(7.8%)在 15 年的随访中死亡。在调整性别后,那些经历过 1、2 和 3-4 次病例水平情感症状的人分别有 76%、87%和 134%的过早死亡率,而从未经历过病例水平症状的人则没有。仅在青春期(13-15 岁)经历病例水平症状与死亡率增加 94%有关,在充分调整协变量后,这一关系无法解释(风险比,1.73;95%CI,1.10-2.72)。那些有多次(2-4 次)病例水平症状的参与者与死亡率之间的关联主要由成年期健康指标和行为解释。例如,有 3-4 次病例水平症状的参与者的关联因健康状况数量(32.1%)、抗焦虑药物使用(28.4%)、肺功能(24.6%)、体力活动(23.9%)、吸烟(24.6%)、抗抑郁药物使用(20.1%)、饮食(16.4%)、脉搏率(12.7%)和成年社会阶层(11.2%)而明显减弱。
情感症状的终生累积可能与死亡率的增加有关,其解释途径取决于症状的持续时间和出现时间。未来的因果关系途径和潜在干预点的研究应考虑情感症状史。